Inhibition of neutrophil migration by a selective inhibitor of matrix metalloproteinase: analysis by intravital microscopy by Oda, T. et al.
Research Paper
Mediators of Inflammation 4, 133-137 (1995)
OBSERVATION of the microcirculation of the hamster cheek
pouch by intravital microscopy revealed five steps of
neutrophil migration from the venules after topical appli-
cation of leukotriene B to the microvasculature: rolling
along the venular wall (Step 1), adhesion to it (Step 2),
disappearance from the vascular lumen (Step 3), pres-
ence between the endothelial cells and the subendothelial
basement membrane (Step 4) and passage through the
basement membrane (Step 5). The present study was
performed to examine whether a metalloproteinase in-
hibitor inhibits neutrophil migration at any of the above
five steps. Chymostatin and leupeptin did not inhibit any
of these five steps. In contrast, FN-439, a selective inhibi-
tor of matrix metalloproteinase, reduced the number of
neutrophils in the perivascular space without affecting
Steps 1 to 3. It was concluded that neutrophils may use
metalloproteinase (collagenase/gelatinase) to penetrate
the subendothelial basement membrane.
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Introduction
Migration of polymorphonuclear leukocytes,
mainly neutrophils, from the circulation to the
extravascular space is one of the cardinal signs of the
acute inflammatory response. A study of
chemoattractant-induced migration of neutrophils in
the microcirculation of the hamster cheek pouch by
intravital microscopy has demonstrated five steps
from the circulation to the extravascular space. Once
chemoattractants such as leukotriene (LT) B or fMLP
(N-formyl-methionyl-leucyl-phenylalanine) are ap-
plied over the mirovasculature, neutrophil numbers
rolling on the inner surface of the venules did not
always increase, compared with that before
chemoattractants (Step 1), but neutrophils adhere to
the endothelial cells (Step 2), pass through the
endothelial cell layer (Step 3), remain in the space
between the endothelial cells and the subendothelial
basement membrane for longer than 30 min (Step 4),
as revealed by electron micrography, and finally
penetrate the basement membrane of endothelial
cells and pericytes (Step 5). A glucocorticosteroid,
dexamethasone, inhibits neutrophil migration by
selective inhibition of the last step of the penetration
of the basement membrane (Step 5)."
The aim of the present study was to test whether
neutrophils require matrix metalloproteinase in the
process of migration from the venules or passage
through the basement membrane. The results indi-
cated that Step 5 was inhibited by a selective in-
hibitor of matrix metalloproteinase (collagenase/
gelatinase), suggesting that the passage might be
completed if, for example, type IV collagen were
cleaved by collagenase/gelatinase.
Materials and Methods
Preparation ofhamster cheekpouch: Hamster cheek
pouches were prepared as described previously.>3
Male golden hamsters (120-150 g, 10-16 weeks old,
Nihon SLC, Shizuoka, Japan) were anaesthetized
with pentobarbital (Nembutal, Abbot Lab., Chicago,
IL, USA) (60 mg/kg body weight, intraperitoneally),
and their cheek pouches were everted, cut longit-
udinally, and extended. The connective tissue was
elaborately dissected away to expose the micro-
vasculature of the mucous layer. The thin mucous
membrane tissue was spread out in a plastic chamber
and superfused with 5 ml/min of warmed Tyrode’s
solution, which was kept at 37C. Body temperature
was maintained at 37C by a warming-pad controller
positioned directly beneath the hamster. Tracheal
intubation ensured spontaneous respiration.
Microscopic observation and recording of leukocyte
behaviour: The microvasculature of the hamster
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cheek pouch was observed under a transillumination
microscope (BHA, Olympus Optical Co., Ltd, Tokyo,
Japan), using a w40 water immersion lens (x40,
Nikon, Tokyo, Japan) and xl0 eyepieces (Olympus
Optical Co., Ltd, Tokyo, Japan). Images of the
microcirculation were projected onto a colour televi-
sion (TV) monitor screen (CMM20-7HR, Shibasoku,
Tokyo, Japan) via a colour TV camera (CTC-2600,
Ikegami Tsushinki, Tokyo, Japan) mounted at the top
of the microscope, as described previously. 1-3
The behaviour of the leukocytes in each experi-
ment were usually recorded with a videotape
recorder (VO-5850, Sony Co., Tokyo, Japan) and
reviewed after the experiments. The images of indi-
vidual leukocytes during migration were viewed on
the screen. The experimental procedures were per-
formed only once in each animal. The behaviour of
a leukocyte over a 100/.tm length of a postcapillary
venule with a diameter of 13-15/.tm was observed on
the monitor screen. Over a 30 min equilibration
period, leukocytes were rolling along the
endothelium of the venules at a lower velocity than
were erythrocytes.
Chemotactic agent and proteinase inhibitors:
Leukotriene (LT) B (Paesel, GMBH, Frankfurt, Ger-
many) was used as a chemoattractant. A stock solu-
tion of LTB4 (30/.tM in absolute ethanol) was kept at
-80C and diluted to 300 nM with Tyrode’s solution
immediately before use. The superfusion of the
cheek pouch with Tyrode’s solution was stopped
during the experiments. LTB (15 pmol/50 /.tl) was
applied to the microvasculature at the observation
site with a 50/.tl micropipette.
FN-439 is a tetrapeptidyl hydroxamic acid with
the structure p-NHi-Bz-GIy-Pro-D-Leu-D-Ala-NHOH,
which is a selective inhibitor of matrix metal-
loproteinase (collagenase/gelatinase; Fuji Chemical
Industry, Toyama, Japan). A sample of FN-439 was
dissolved in Tyrode’s solution at a concentration of
1 mM, and 50 nmol/50 /.tl of the resulting solution
was applied to the microvasculature 5 min after a
single LTB application and every 5 min thereafter for
a total of ten times. Chymostatin (an inhibitor of
cathepsins A, B and D; the Peptide Institute, Minoh,
Osaka, Japan) and leupeptin (an inhibitor of trypsin
and cathepsin B; the Peptide Institute, Minoh, Osaka)
were separately dissolved in Tyrode’s solution, and
50/.tl samples of these solutions were applied to the
microvasculature in the same way as FN-439.
Results
Figure 1 shows the effects of the inhibitors of
different enzymes on the cumulative number of
newly adhering neutrophils over a 100/.tm length of
a venule during a 50-min period after topical appli-
cation of LTB (15 pmol/50/.tl). The total number of
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FIG. 1. Effects of the proteinase inhibitors on the cumulative number of
neutrophils newly adhering to the inner venular wall for 50 min after appli-
cation of LTB4. LTB, (300 nM, 50 !1) was applied topically over the
microvasculature. Col.l., collagenase/gelatinase inhibitor (FN-439, mM).
Chy, chyostatin (1 mM). Leu, leupeptin. These proteinase inhibitors (50
!1) were applied over the microvasculature 5 min before and every 5 min
after LTB, application. The values represent mean S.E.M. The numbers
at the top of the columns indicate the numbers of animals used.
newly adhering neutrophils was 32.0 + 6.0 during
this period. Fifty /.tl of the solutions of the
collagenase/gelatinase inhibitor (FN-439) (1 mM),
chymostatin (1 mM) and leupeptin (1 mM), applied
5 min after LTB and every 5 min thereafter, did not
provide any significant inhibitory effect on the cumu-
lative number of neutrophils newly adhering to the
venular wall.
The numbers of neutrophils that disappeared from
the venular lumen as percentages of the numbers of
neutrophils that had adhered to the inner wall of
venules are shown in Fig. 2. LTB induced the disap-
pearance of nearly 100% of the neutrophils, that had
adhered to the venular wall, from the vascular lumen
through the endothelial layer. None of the inhibitors
applied topically inhibited this passage of the
neutrophils into the venular wall.
Figure 3 shows the numbers of neutrophils that
appeared in the perivascular space, observed up to
90 min after topical application of LTB4. The number
of neutrophils increased with time from 30 min after
the application. Chymostatin and leupeptin did not
significantly modify the numbers of neutrophils in
the perivascular space. FN-439, however, signifi-
cantly reduced these numbers, from 3.0 + 0.4 to 0.4
+ 0.2 in 30 min, from 12.6 + 0.8 to 2.2 + 0.8 in 60 min,
and from 19.8 + 1.0 to 4.4 + 1.0 in 90 min.Neutrophil migration and a collagenase inhibitor
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FIG. 2. Effects of proteinase inhibitors on the number of neutrophils that
disappeared from the venular lumen as a percentage of the adhering
neutrophil count. EC, endothelial cells. For other abbreviations, see Fig. 1.
Application of the inhibitors was made in the same way as for Fig.l. The
values represent mean S.E.M. The numbers of animals were the same
as in Fig. 1.
Discussion
Migration of neutrophils at the level of
microcirculation in hamster cheek pouch is not a
simple phenomenon, but involves five steps, as re-
ported in the previous paper. Step 1, rolling on the
venular wall, may be attributed to the selectin type
of adhesion molecule. 5,6 Step 2, adhesion of
neutrophils to the venular wall, is initiated by a
change in the neutrophil membrane and may be due
to activation of the adhesion molecule, CD11/CD18,
since the adhesion of neutrophils was inhibited by
the antibody against rat CD18. The observation in
the present experiments that the number of
neutrophils adhering to the venules was not reduced
by chymostatin, leupeptin or FN-439 may indicate
that in this adhesion step, neutrophils did not require
proteolytic enzymes such as cathepsins A, B and D
or metalloproteinases for adhesion to the endothelial
cells. Involvement of other proteinases in this pro-
cess cannot be excluded in the present study.
These enzyme inhibitors also did not suppress the
rate of disappearance of neutrophils from the venular
lumen (Step 3), indicating that the passage of the
neutrophils between the endothelial cells may not
require the action of proteolytic enzymes.
We were unable to study the effect of inhibitors on
the neutrophils which remained in the venular wall
between the endothelial cell layer and the venular
basement membrane (Step 4), owing to the lack of
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FIG. 3. Effects of proteinase inhibitors on the neutrophil counts in the perivascular space 30, 60 and 90 min after application of LTB4. For the abbreviations,
see Fig. 1. Application of the inhibitors was made in the same way as for Fig. up to 90 min. The values were compared with that for LTB alone. The counts
after application of a collagenase/gelatinase inhibitor (FN-439) were significantly reduced (*p < 0.05). The numbers of animals were the same as in Fig. 1.
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basement membrane (Step 4), owing to the lack of
a method for evaluation. Nevertheless, the fact that
the number of neutrophils counted in the
perivascular space was not affected by topical appli-
cation of chymostatin or leupeptin indicated that
these proteinase inhibitors did not affect the move-
ment within the venular wall. Alternatively, it sug-
gested that proteolytic enzymes such as cathepsins A,
B and D were not required for neutrophils to trans-
migrate through the basement membrane to the
perivascular space (Step 5). In contrast, the number
of neutrophils counted in the perivascular space after
topical application of LTB was markedly reduced by
FN-439. FN-439 was reported to inhibit the human
skin collagenases, human granulocyte collagenase
and tadpole collagenase at IC50 values of 1.3 btM, 0.9
t.tM and 1.1 l-tM, respectively and granulocyte
gelatinase and skin fibroblast stromelysin at IC50
values of 30 laM and 150 btM, but no apparent
inhibition was observed against thermolysin, urease,
trypsin, 0-chymotrypsin, plasmin and human
granulocyte elastase. Alkali-induced corneal ulcera-
tion in rabbit eyes was prevented by FN-439. The
inhibition of neutrophil migration to the perivascular
space observed in the present study clearly indicated
that the neutrophils use matrix metalloproteinase to
cleave a part of the basement membrane or type IV
collagen for passage through this membrane. The
videotape image in the present study revealed that
neutrophils were going out, one by one, from a part
of the venular wall to the perivascular space 1 h after
the application of LTB4.
In vessel wall constructs in vitro,
1 using
endothelial cells from human umbilical vein, which
were cultured on type collagen and synthesized
continuous subendothelial basement membrane, the
permeability increase of Monastral Blue B colloid by
neutrophils and neutrophil emigration were not pre-
vented by inhibitors of the serine protease, elastase
and cathepsin G (DFP, aprotinin, leupeptin,
pepstatin and others), by a natural metalloproteinase
inhibitor (a tissue inhibitor of metalloproteinases,
TIMP) and by inhibitors of endoglycosidase and
heparanase (heparin). These in vitro results, showing
that the loss of basement membrane integrity associ-
ated with neutrophil diapedesis was independent of
the neutrophil proteases, were consistent with those
in the present study, but the failure of the inhibition
by TIMP might be due to rapid destruction of the
endogenous inhibitor, whereas FN-439 was reported
to be resistant to hydrolysis by pronase.
It has been reported
11 (1) that human neutrophils
secrete specific granule contents (e.g., lysozyme and
Bla-binding protein), but not azurophil granule con-
tents (e.g., [-glucuronidase), during migration across
the micropore filters of modified Boyden chambers
in response to a chemoattractant; (2) that specific
granule products, but not azurophil granule prod-
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ucts, were detected in the extracellular fluid of ex-
perimental human skin chambers or skin blisters
in vivo, coincident with the influx of exudate
neutrophils, and (3) that a loss of specific granules,
but not azurophil granules, from exudate cells was
demonstrated in these models. These findings may
well account for the results in the present studies,
since collagenase is reported to be present in specific
granules, while elastase is found in the azurophil
granules of human neutrophils.
12
It is not clear whether metalloproteinases are syn-
thesized in neutrophils during their presence within
the venular wall for longer than 30 min in the
hamster cheek pouch. It was reported13 that adhe-
sion to covalently immobilized peptides containing
the Arg-Gly-Asp sequence that were derived from
fibronectin induced collagenase and stromelysin
gene expression. In an in vitro model of a barrier of
endothelial cells, TM neutrophils, placed in the upper
compartment of a chemotaxis chamber, extend their
pseudopods into filters with a pore size of less than
0.61am, in response to the gradient of the
chemoattractant. The bulk of the cytoplasmic gran-
ules, the centriole and the Golgi apparatus are to-
ward the front of the cell just behind the hyaline- and
microfilament-filled pseudopods. This location may
facilitate the secretion of granular contents towards
the front portion of the cell during migration.
Pretreatment of rabbits with cycloheximide or
actinomycin D was reported to inhibit neutrophil
migration induced by interleukin-1, tumour necrosis
factor-o or endotoxin, but not that by C5a-des-Arg,
fMLP or LTB4 .15 In contrast, 72-kDA gelatinase was
induced on T cells, when they bind to VCAM-1 on
the surface of endothelial cells.6
We reported previously that dexamethasone in-
hibits migration at Step 5. This is in accord with the
finding that induction of the gene expression of
metalloproteinase in fibroblasts by the Arg-Gly-Asp
sequence was inhibited by dexamethasone. 13 It can-
not be concluded whether metalloproteinases are
synthesized in neutrophils or the proteinases already
synthesized are secreted, but these results, taken
together, suggest that the period in which
neutrophils remained in the space between the
endothelial cells and the subendothelial basement
membrane in the present experiment, may be neces-
sary for the neutrophils to synthesize the
metalloproteinase or to prepare to secrete this en-
zyme.
Our present results suggest that a metallo-
proteinase inhibitor such as FN-439 may be a poten-
tial therapeutic drug that would prevent neutrophil
migration in inflammatory diseases such as rheuma-
toid arthritis. In conclusion, neutrophils may use
metalloproteinase or collagenase/gelatinase, at the
stage of passage through the subendothelial base-
ment membrane during their transmigration.Neutrophil migration and a collagenase inhibitor
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